sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Systemic Aspergillosis And Systemic Candidasis Market Scope And Analysis

  • Report Code : TIPRE00016906
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Systemic Aspergillosis and Systemic Candidasis Market Scope 2031

Buy Now

Systemic Aspergillosis and Systemic Candidasis Market Report Systemic Aspergillosis and Systemic Candidasis Market Size and Share Systemic Aspergillosis and Systemic Candidasis Market Scope and Analysis

Systemic Aspergillosis and Systemic Candidasis Market Report Scope

Report Attribute Details
Market size in 2023 US$ 6.73 Billion
Market Size by 2031 US$ 10.03 Billion
Global CAGR (2023 - 2031) 4.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Voriconazole
  • Liposomal
  • Amphotericin B
  • Systemic Oral Azoles
  • Topical
  • Antifungal Agents
By Application
  • Chronic
  • Pulmonary Aspergillosis
  • Allergic
  • Bronchopulmonary Aspergillosis
  • Gastrointestinal Candidiasis
  • Genitourinary Tract Candidiasis
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Novartis AG
  • Sanofi Aventis
  • Pfizer Inc
  • Merck and Co Inc
  • Enzon Pharmaceuticals Inc
  • Bayer AG
  • Astellas Pharma Inc
  • GlaxoSmithKline plc
  • Abbott
  • Cipla
    		•